Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Appointed director
Director departure

NANOMIX Corp (BTHE) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/26/2023 3 Hetterly Chris (CFO) has filed a Form 3 on NANOMIX Corp
12/21/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
12/19/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
12/19/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
12/16/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
12/16/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
09/21/2022 3 GRUENER GARRETT (10% Owner) has filed a Form 3 on NANOMIX Corp
06/29/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
03/07/2018 3 Upham Loraine (COO) has filed a Form 3 on Boston Therapeutics, Inc.
05/10/2017 3 Form 3 - Initial statement of beneficial ownership of securities
01/25/2012 3 Lueders Carl Laurence (Director) has filed a Form 3 on Boston Therapeutics, Inc.
01/25/2012 3 Eliaz Rom E (Director) has filed a Form 3 on Boston Therapeutics, Inc.
01/25/2012 3 Binder Offer (10% Owner) has filed a Form 3 on Boston Therapeutics, Inc.
01/25/2012 3 CONAWAY DALE H (Director) has filed a Form 3 on Boston Therapeutics, Inc.
01/25/2012 3 PLATT DAVID (Chairman, CEO) has filed a Form 3 on Boston Therapeutics, Inc.
01/25/2012 3 Tassey Kenneth A. Jr (President, COO) has filed a Form 3 on Boston Therapeutics, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy